---
title: "Talis Biomedical (TLIS.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TLIS.US.md"
symbol: "TLIS.US"
name: "Talis Biomedical"
industry: "Health Care Equipment"
datetime: "2026-05-21T14:22:23.582Z"
locales:
  - [en](https://longbridge.com/en/quote/TLIS.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TLIS.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TLIS.US.md)
---

# Talis Biomedical (TLIS.US)

## Company Overview

Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other strategic transactions. Talis Biomedical Corporation was incorporated in 2013 and is based in Chicago, Illinois.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:19.000Z

**Overall: D (0.78)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 179 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -85.69% |  |
| Net Profit YoY | 40.54% |  |
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 0.00 |  |
| Revenue | 408000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -70.48% | E |
| Profit Margin | -12506.37% | E |
| Gross Margin | 0.00% | E |
| Revenue YoY | -85.69% | E |
| Net Profit YoY | 40.54% | B |
| Total Assets YoY | -40.93% | E |
| Net Assets YoY | -49.44% | E |
| Cash Flow Margin | -0.80% | D |
| OCF YoY | -85.69% | E |
| Turnover | 0.00 | E |
| Gearing Ratio | 33.11% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Talis Biomedical",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-85.69%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "40.54%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.00",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "0.00",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "408000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-70.48%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-12506.37%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "0.00%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "-85.69%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "40.54%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "-40.93%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-49.44%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-0.80%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-85.69%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.00",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "33.11%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.06 | 52/183 | - | - | - |
| PB | 0.06 | 1/183 | 0.06 | 0.06 | 0.06 |
| PS (TTM) | 7.15 | 102/183 | 7.15 | 7.15 | 6.70 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/TLIS.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/TLIS.US/norm.md)
- [Related News](https://longbridge.com/en/quote/TLIS.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/TLIS.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**